Kyverna Therapeutics, Inc.KYTXNASDAQ
LOADING
|||
Gross Profit Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
19.42%
↓ 45% below average
Average (11q)
35.46%
Historical baseline
Range
High:100.00%
Low:-2.79%
Volatility
289.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 19.42% |
| Q2 2025 | -2.79% |
| Q1 2025 | 11.01% |
| Q4 2024 | 98.07% |
| Q3 2024 | 0.00% |
| Q2 2024 | 100.00% |
| Q1 2024 | 99.87% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 100.00% |
| Q4 2022 | 0.00% |